These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37141876)

  • 1. [Treatment of eosinophilic esophagitis - advancements and perspectives].
    Miehlke S; Arnim UV; Schlag C; Labenz J; Madisch A
    Laryngorhinootologie; 2023 May; 102(5):339-348. PubMed ID: 37141876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of eosinophilic esophagitis - advancements and perspectives].
    Miehlke S; von Arnim U; Schlag C; Labenz J; Madisch A
    Z Gastroenterol; 2021 Aug; 59(8):869-878. PubMed ID: 34157757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?
    Walgraeve S; Vanuytsel T
    Acta Gastroenterol Belg; 2023; 86(3):437-448. PubMed ID: 37814560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.
    Nennstiel S; Schlag C
    World J Gastroenterol; 2020 Sep; 26(36):5395-5407. PubMed ID: 33024392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
    Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
    United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.
    Miehlke S; Lucendo AJ; Straumann A; Jan Bredenoord A; Attwood S
    Therap Adv Gastroenterol; 2020; 13():1756284820927282. PubMed ID: 32565912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
    Munoz-Persy M; Lucendo AJ
    Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies for eosinophilic esophagitis.
    Greuter T; Hirano I; Dellon ES
    J Allergy Clin Immunol; 2020 Jan; 145(1):38-45. PubMed ID: 31705907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insights on the use of topical steroids in eosinophilic esophagitis.
    Reddy A; Ashat D; Murali AR
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
    Lucendo AJ; Miehlke S; Schlag C; Vieth M; von Arnim U; Molina-Infante J; Hartmann D; Bredenoord AJ; Ciriza de Los Rios C; Schubert S; Brückner S; Madisch A; Hayat J; Tack J; Attwood S; Mueller R; Greinwald R; Schoepfer A; Straumann A;
    Gastroenterology; 2019 Jul; 157(1):74-86.e15. PubMed ID: 30922997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.
    Andrist CM; Jörg L; Greuter T; Gschwend A; Straumann A; Helbling A
    BMC Gastroenterol; 2020 Dec; 20(1):419. PubMed ID: 33308158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.
    Greuter T; Alexander JA; Straumann A; Katzka DA
    Clin Transl Gastroenterol; 2018 Dec; 9(12):e212. PubMed ID: 30802222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
    Straumann A; Lucendo AJ; Miehlke S; Vieth M; Schlag C; Biedermann L; Vaquero CS; Ciriza de Los Rios C; Schmoecker C; Madisch A; Hruz P; Hayat J; von Arnim U; Bredenoord AJ; Schubert S; Mueller R; Greinwald R; Schoepfer A; Attwood S;
    Gastroenterology; 2020 Nov; 159(5):1672-1685.e5. PubMed ID: 32721437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of treatment with budesonide orodispersible tablets in 76 patients with eosinophilic oesophagitis - real-life experience from the population-based DanEoE cohort.
    Frandsen LT; Melgaard D; Hansen SK; Mørk K; Krarup AL
    Scand J Gastroenterol; 2024 Oct; 59(10):1137-1143. PubMed ID: 39267404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis.
    Tomizawa Y; Melek J; Komaki Y; Kavitt RT; Sakuraba A
    J Clin Gastroenterol; 2018 Aug; 52(7):596-606. PubMed ID: 28787360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment strategies for eosinophilic esophagitis in adults.
    Lucendo AJ
    Expert Opin Pharmacother; 2022 May; 23(7):827-840. PubMed ID: 35379069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic and Clinical Effects of Different Topical Corticosteroids for Eosinophilic Esophagitis: Lessons from an Updated Meta-Analysis of Placebo-Controlled Randomized Trials.
    de Heer J; Miehlke S; Rösch T; Morgner A; Werner Y; Ehlken H; Becher H; Aigner A
    Digestion; 2021; 102(3):377-385. PubMed ID: 32610332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Treatment of Eosinophilic Esophagitis: An Update.
    Schoepfer AM; Straumann A; Safroneeva E
    Gastrointest Endosc Clin N Am; 2018 Jan; 28(1):77-88. PubMed ID: 29129301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
    Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR
    Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in Practices of Compounding Budesonide for Eosinophilic Esophagitis.
    Joshi S; Rubenstein JH; Dellon ES; Worthing N; Stefanadis Z; Chang JW
    Am J Gastroenterol; 2021 Jun; 116(6):1336-1338. PubMed ID: 33538420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.